Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial

NEO-RACo Study Group

doi:10.3899/jrheum.140267

Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial

NEO-RACo Study Group

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Pages (from-to)	2379-2385
Journal	JOURNAL OF RHEUMATOLOGY
Volume	41
Issue number	12
DOIs	https://doi.org/10.3899/jrheum.140267
Publication status	Published - 2014
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 2

Access to Document

10.3899/jrheum.140267

Cite this

NEO-RACo Study Group (2014). Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial. JOURNAL OF RHEUMATOLOGY, 41(12), 2379-2385. https://doi.org/10.3899/jrheum.140267

NEO-RACo Study Group. / Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial. In: JOURNAL OF RHEUMATOLOGY. 2014 ; Vol. 41, No. 12. pp. 2379-2385.

@article{ae0f344591b04ffa9641e60e396419cc,

title = "Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial",

author = "{NEO-RACo Study Group} and Vappu Rantalaiho and Anu Mustila and Anna Karjalainen and Leena Paimela and Toini Uutela and Marjatta Leirisalo-Repo and Eeva Moilanen and Riina Nieminen and Katriina Vuolteenaho and Hannu Kautiainen and Salme J{\"a}rvenp{\"a}{\"a} and Markku Korpela and Timo Malmi and Pekka Hannonen and Oili Kaipiainen-Sepp{\"a}nen and Timo Yli-Kerttula and Timo M{\"o}tt{\"o}nen",

year = "2014",

doi = "10.3899/jrheum.140267",

language = "English",

volume = "41",

pages = "2379--2385",

journal = "JOURNAL OF RHEUMATOLOGY",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "12",

}

NEO-RACo Study Group 2014, 'Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial', JOURNAL OF RHEUMATOLOGY, vol. 41, no. 12, pp. 2379-2385. https://doi.org/10.3899/jrheum.140267

Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial. / NEO-RACo Study Group.
In: JOURNAL OF RHEUMATOLOGY, Vol. 41, No. 12, 2014, p. 2379-2385.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial

AU - NEO-RACo Study Group

AU - Rantalaiho, Vappu

AU - Mustila, Anu

AU - Karjalainen, Anna

AU - Paimela, Leena

AU - Uutela, Toini

AU - Leirisalo-Repo, Marjatta

AU - Moilanen, Eeva

AU - Nieminen, Riina

AU - Vuolteenaho, Katriina

AU - Kautiainen, Hannu

AU - Järvenpää, Salme

AU - Korpela, Markku

AU - Malmi, Timo

AU - Hannonen, Pekka

AU - Kaipiainen-Seppänen, Oili

AU - Yli-Kerttula, Timo

AU - Möttönen, Timo

PY - 2014

Y1 - 2014

U2 - 10.3899/jrheum.140267

DO - 10.3899/jrheum.140267

M3 - Article

SN - 0315-162X

VL - 41

SP - 2379

EP - 2385

JO - JOURNAL OF RHEUMATOLOGY

JF - JOURNAL OF RHEUMATOLOGY

IS - 12

ER -

NEO-RACo Study Group. Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial. JOURNAL OF RHEUMATOLOGY. 2014;41(12):2379-2385. doi: 10.3899/jrheum.140267